Document Detail

Uric Acid nephrolithiasis: recent progress and future directions.
MedLine Citation:
PMID:  17396168     Owner:  NLM     Status:  In-Data-Review    
The prevalence of urolithiasis has been increasing for the past few decades in industrialized nations. Uric acid calculi account for a significant percentage of urinary stones. Certain risk factors may be involved in the pathogenesis of uric acid nephrolithiasis, including hyperuricosuria, low urinary volume, and persistently low urinary pH. Patients with medical conditions that promote profound hyperuricosuria are at high risk of developing uric acid calculi. These conditions include chronic diarrheal states; myeloproliferative disorders; insulin resistance, including diabetes mellitus; and monogenic metabolic disorders, such as Lesch-Nyhan syndrome. Computed tomography can provide a definitive diagnosis. Except in cases in which there is severe obstruction, progressive azotemia, serious infection, or unremitting pain, the initial treatment of patients with uric acid nephrolithiasis should be medical dissolution therapy because this approach is successful in the majority of cases. A thorough review of the epidemiology and pathophysiology of uric acid nephrolithiasis is crucial for the diagnosis, treatment, and prevention of stones in patients with this condition.
Tin C Ngo; Dean G Assimos
Related Documents :
16014058 - Correlation of uric acid and urinary albumin excretion rate in patients with type 2 dia...
15241498 - Uric acid or 1-methyl uric acid in the urinary bladder increases serum glucose, insulin...
15746438 - Association between serum uric acid, metabolic syndrome, and carotid atherosclerosis in...
7952068 - Determination of ascorbic acid and uric acid in plasma by high-performance liquid chrom...
6146438 - Low forestomach acidity in the rat and the role of the gastric bolus.
3528138 - Characterization of the fatty acid synthetase system of curtobacterium pusillum.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Reviews in urology     Volume:  9     ISSN:  1523-6161     ISO Abbreviation:  Rev Urol     Publication Date:  2007  
Date Detail:
Created Date:  2007-03-30     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100889067     Medline TA:  Rev Urol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  17-27     Citation Subset:  -    
Department of Urology, Wake Forest University School of Medicine Winston-Salem, NC.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Diagnosis of interstitial cystitis/ painful bladder syndrome in patients with overactive bladder sym...
Next Document:  Is the testis a chemo-privileged site? Is there a blood-testis barrier?